MedTrace Logo

Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.

NCT01883596 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2015-12-08

No results posted yet for this study

Summary

To determine the efficacy of prophylaxis with 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

Conditions

  • Mechanical Ventilation for More Than 48 Hours.

Interventions

DRUG

0.12% chlorhexidine solution

Bexident® (0.12% chlorhexidine solution)

DRUG

Placebo

7.4% alcohol, glycerine, normal saline solution, applied topically, every 8 hrs.

Sponsors & Collaborators

  • Sinaloa Pediatric Hospital

    lead OTHER

Principal Investigators

  • Jesus J Martinez, MD · Sinaloa Pediatric Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-10-31
Completion
2016-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01883596 on ClinicalTrials.gov